Company: BLCO
Filing Date: 2025-07-30
Form Type: 10-Q
Source: 0001860742-25-000018
Chunk: 126

Company: Bausch & Lomb Corp
Filing Date: 2025-07-30
Form: 10-Q
Item: Item 2
Chunk 126
---
 30, 2024Revenues Our revenues were $2,415 million and $2,315 million for the six months ended June 30, 2025 and 2024, respectively, an increase of $100 million, or 4%. The increase was attributable to: (i) increased volumes of $127 million across each of our segments, (ii) incremental sales attributable to acquisitions of $12 million, within our Surgical segment and (iii) the favorable impact of foreign currencies of $2 million. The increases in revenue were partially offset by: (i) decreased net realized pricing of $38 million, driven by our Pharmaceuticals segment and (ii) the impact of divestitures and discontinuations of $3 million, relating to the discontinuation of certain products within our Vision Care segment.The following table presents segment revenues, segment revenues as a percentage of total revenues and the period-over-period changes in segment revenues for the six months ended June 30, 2025 and 2024. 20252024Change(in millions)AmountPct.AmountPct.AmountPct.Segment RevenuesVision Care$1,409 58 %$1,332 57 %$77 6 %Pharmaceuticals576 24 %577 25 %(1)— %Surgical430 18 %406 18 %24 6 %Total revenues$2,415 100 %$2,315 100 %$100 4 %Constant Currency Revenues and Constant Currency Revenue Growth (non-GAAP)The following table presents a reconciliation of Revenues to constant currency revenues (non-GAAP) and the period-over-period changes in constant currency revenue (non-GAAP) for the six months ended June 30, 2025 and 2024. Constant Currency Revenues (non-GAAP) and Constant Currency Revenue Growth (non-GAAP) are defined in the previous section titled “Constant Currency Revenues and Constant Currency Revenue Growth (non-GAAP)”. Six Months Ended June 30, 2025Six Months Ended June 30, 2024Change inConstant Currency Revenue (Non-GAAP)RevenueasReportedChanges in Exchange RatesConstant Currency Revenue (Non-GAAP)RevenueasReported(in millions)AmountPct.Vision Care$1,409 $(1)$1,408 $1,332 $76 6 %Pharmaceuticals576 — 576 577 (